Rowing Exercise Program for Breast Cancer Survivors
Rowing Following Breast Cancer Chemotherapy
Recruiting
N/A
Interventional Study
Breast Cancer Survivors
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 40 – 80
- Sex
- Female
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 72 (estimated)
- Sponsor
- University of Florida · Other
Who this trial is looking for
This trial is looking for female breast cancer survivors aged 40 to 80 who have completed treatment 6 to 24 months ago. Participants will engage in a rowing exercise program aimed at improving heart health.
Are You a Good Fit for This Trial?
You may be able to join if
- I am a female breast cancer survivor aged 40 to 80.
- I have been diagnosed with primary invasive non-metastatic breast cancer, stages I-III.
- I completed my breast cancer treatment 6 to 24 months ago.
- I have no issues that prevent me from exercising.
- I have my doctor's approval to participate.
You may not be able to join if
- I am currently receiving treatment for breast cancer.
- I have had lymphedema stage 2 or higher before the study.
- I have a history of relevant cardiovascular disease.
- I have been regularly rowing for 150 minutes or more each week in the last 6 months.
- I am participating in other experimental treatments that could affect this study.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
There are more than 3.8 million breast cancer survivors in the United States and cancer survivors have a higher risk of cardiovascular disease (CVD) due to chemotherapy than adults without cancer. Cardiovascular rehabilitation can be an effective strategy to decrease the incidence of CVD and its risk factors in this population. The proposed study may help to examine the effect of a novel exercise …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* diagnosis of primary invasive non-metastatic breast cancer, stages I-III
* female based on biological sex
* 40 to 80 years of age
* completed breast cancer treatment 6 to 24 months prior to study enrollment. Adjuvant endocrine therapy for breast cancer (e.g., ovarian suppressi…
Contacts